This study exists to see whether the medication Aripiprazole can make care clearer and more responsive. Researchers are trying to understand whether the medication Aripiprazole can give earlier or clearer feedback during care.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Bipolarity

View study

CompletedNCT00585910

Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

View study

CompletedNCT00001915

Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDOther

Countries: United States
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Condition: ADHD

View study

CompletedNCT00516919

Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersBehavioralFrom 18 Years to 60 Years

Countries: United States
Sponsor: Yale University
Condition: Eating disorders

View study

CompletedNCT01849432

Brain Circuitry in Anxiety Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Anxiety, PTSDOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Anxiety, PTSD

View study

CompletedNCT04306146

CAD-9303 in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Cadent Therapeutics
Condition: Schizophrenia

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.